prostate cancer

Lots of Prostate Cancer Radiation Options, Little Clue What Works
Thu, 04/22/10 - 10:25 am
prostate cancer
radiation
Dendreon touts Provenge test results
Bizjournals.com
Wed, 04/21/10 - 03:52 pm
Provenge
prostate cancer
Dendreon
How much is too much to pay for Provenge?
Fierce Biotech
Wed, 04/14/10 - 11:34 am
Provenge
Dendreon
prostate cancer
A blockbuster FDA deadline looms and Dendreon shares turn red-hot
Fierce Biotech
Wed, 04/7/10 - 11:46 am
Dendreon
Provenge
FDA
prostate cancer
1 Month to Go! Is Dendreon a Buy?
Motley Fool
Mon, 04/5/10 - 07:11 pm
Dendreon
Provenge
prostate cancer
Novartis, Orion’s Stalevo Drug May Have Cancer Risk
Bloomberg
Thu, 04/1/10 - 09:42 am
Novartis
Orion
Stalevo
prostate cancer
Parkinson's Disease
US FDA accepts Abbott's six-month 45-mg formulation of Lupron sNDA for review
Pharmabiz
Sat, 03/13/10 - 11:07 am
Abbott Laboratories
Lupron
prostate cancer
Roche’s Avastin Fails to Meet Goal of Prostate Study
Bloomberg
Fri, 03/12/10 - 09:05 am
Roche
Avastin
prostate cancer
Dendreon and the Prostate Cancer Battle
Minyanville
Thu, 03/4/10 - 06:06 pm
Dendreon
Provenge
prostate cancer
Rogue Analyst Provides Questionable Fodder for Dendreon Conspiracy Theorists
BNET Pharma
Thu, 03/4/10 - 07:15 am
Provenge
prostate cancer
Dendreon
Sanofi's Cancer Drug May Set New Standard
TheStreet.com
Thu, 03/4/10 - 07:13 am
Sanofi
cabazitaxel
Medivation
JNJ
Provenge
Dendreon
prostate cancer
Adamis Pharma signs pact to acquire prostate cancer drug candidates from Colby Pharma
Pharmabiz
Sat, 02/27/10 - 01:23 pm
Adamis Pharmaceuticals
prostate cancer
Dendreon Redux
Seeking Alpha
Sun, 02/21/10 - 11:16 am
Dendreon
Provenge
prostate cancer
J&J's prostate cancer drug proves promising in Ph2
Fierce Biotech
Wed, 02/17/10 - 06:55 pm
prostate cancer
JNJ
abiraterone
Amgen Tops Novartis at Reducing Fractures in Prostate Patients
Bloomberg
Tue, 02/9/10 - 09:41 am
Amgen
Novartis
denosumab
prostate cancer
Zometa
FDA Derides ‘Conspiracy Theory’ Over Provenge Delay
Pharmalot
Fri, 02/5/10 - 10:28 am
Provenge
Dendreon
prostate cancer
FDA
Amgen Earnings: D-Mab Cancer Data Could Be the Biggest Biotech Event of 2010
BNET Pharma
Wed, 01/27/10 - 10:46 am
Amgen
earnings
prostate cancer
denosumab
Dendreon sees full Provenge capacity by mid-2011
Reuters
Wed, 01/13/10 - 09:24 am
Dendreon
prostate cancer
Provenge
Sanofi-Aventis Stops Development of Two Medicines
Bloomberg
Mon, 12/21/09 - 09:13 am
Sanofi
insomnia
anti-clotting
prostate cancer
atrial fibrillation
Algeta Announces First US Patient Randomized In ALSYMPCA Phase III Study At Tulane Cancer Center, New Orleans
Medical News Today
Sat, 12/12/09 - 01:29 pm
Algeta
prostate cancer

Pages